Results 151 to 160 of about 30,778 (256)

Preclinical Lutetium-177 Intracellular Dosimetry of Target Cancers in Radionuclide Therapy. [PDF]

open access: yesJ Med Phys
Lunev AS   +4 more
europepmc   +1 more source

Supplementary Figure S.4 from Mathematical Modeling Unveils Optimization Strategies for Targeted Radionuclide Therapy of Blood Cancers

open access: gold
Maxim Kuznetsov   +6 more
openalex   +1 more source

Dosimetry-guided peptide receptor radionuclide therapy in neuroendocrine tumors: interim safety analysis of the DUONEN trial. [PDF]

open access: yesFront Endocrinol (Lausanne)
Kolodziej M   +29 more
europepmc   +1 more source

Supplementary Figure S.1 from Mathematical Modeling Unveils Optimization Strategies for Targeted Radionuclide Therapy of Blood Cancers

open access: gold
Maxim Kuznetsov   +6 more
openalex   +1 more source

Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan–RENATEN Network [PDF]

open access: bronze
Aurelien Fosse   +15 more
openalex   +1 more source

177 Lu-DOTATATE Radionuclide Therapy: Current Status and Trends

open access: diamond, 2023
GE Roytberg   +4 more
openalex   +1 more source

Effects of Targeted Radionuclide Therapy on Cancer Cells Beyond the Ablative Radiation Dose. [PDF]

open access: yesInt J Mol Sci
Ferro-Flores G   +5 more
europepmc   +1 more source

Abstracts

open access: yes
Cancer Science, Volume 117, Issue S1, Page 1-2148, January 2026.
wiley   +1 more source

Home - About - Disclaimer - Privacy